Cytokinetics

📍 South San Francisco, United States🗓 Founded 1998👥 557 employees💰 Last funded 2021
Biotechnology Research🌐 cytokinetics.com
Website LinkedIn
Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. As a leader in muscle biology and the mechanics of muscle performance, we are developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Proud to be a San Francisco Business Times Best Place to Work in 2021 and 2022, a Great Place to Work-Certified company in 2022 and a part of Fortunes Best Workplaces in the Bay Area in 2022 and Fortunes Best Workplaces in BioPharma in 2022.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1998
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Cytokinetics?
Cytokinetics has 1 investors on record on gritt.io.
When did Cytokinetics last raise funding?
The most recent investment in Cytokinetics recorded on gritt.io was in 2021.
When was Cytokinetics founded?
Cytokinetics was founded in 1998.
What industry is Cytokinetics in?
Cytokinetics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Cytokinetics based?
Cytokinetics is headquartered in South San Francisco, United States.